Synthesis of new b-amidodehydroaminobutyric acid derivatives
337
12.36 (br s, 1 H, NH) ppm. 13C NMR (100.6 MHz,
CDCl3): 16.82 (cCH3), 28.24 [C(CH3)3], 52.06 (OCH3),
80.37 [OC(CH3)3], 105.53 (C), 127.63 (CH), 128.83 (CH),
132.38 (CH), 134.13 (C), 154.72 (C), 154.78 (C=O),
165.70 (C=O), 168.46 (C=O) ppm. C17H22N2O5 (334.37):
calcd. C 61.07, H 6.63, N 8.38; found C 60.78, H 6.911, N
8.354.
Synthesis of (E)-methyl 2-(tert-butoxycarbonylamino)-
3-(4-nitrobenzamido)but-2-enoate, E-2d
The general procedure described above was followed with
compound Z-1 (0.25 mmol, 73 mg) as substrate to give
compound E-2d (22 mg, 23 %) as a white solid. M.
p. 179.0–184.0 °C (from ethyl acetate/petroleum ether). 1H
NMR (400 MHz, CDCl3): 1.49 (s, 9 H, CH3 Boc), 2.61 (s,
3 H, cCH3), 3.82 (s, 3 H, OCH3), 5.56 (br s, 1 H, aNH),
8.13 (d, J = 8.8 Hz, 2 H, ArH), 8.35 (d, J = 8.8 Hz, 2 H,
ArH), 12.55 (br s, 1 H, NH) ppm. 13C NMR (100.6 MHz,
CDCl3): 16.75 (cCH3), 28.22 [C(CH3)3], 52.32 (OCH3),
80.66 [OC(CH3)3], 106.73 (C), 124.02 (CH), 128.78 (CH),
139.61 (C), 150.03 (C), 153.85 (C), 154.59 (C=O), 163.50
(C=O), 168.59 (C=O) ppm. HRMS (micrOTOF): calcd. for
C17H21N3NaO7 402.12772; found 402.12717.
The general procedure described above was followed
with compound E-1 (0.25 mmol, 73.5 mg) as substrate to
give compound E-2a (55 mg, 64 %).
Synthesis of (E)-methyl 3-(4-bromobenzamido)-2-(tert-
butoxycarbonylamino)but-2-enoate, E-2b
The general procedure described above was followed with
compound Z-1 (0.5 mmol, 147 mg) as substrate and CuI
(10 mol %) to give compound E-2b (165 mg, 80 %) as a
white solid. M. p. 141.0–142.0 °C (from ethyl acetate/
The general procedure described above was followed
with compound E-1 (0.25 mmol, 73 mg) to give compound
E-2d (34 mg, 36 %).
1
petroleum ether). H NMR (300 MHz, CDCl3): 1.48 (s, 9
H, CH3 Boc), 2.59 (s, 3 H, cCH3), 3.80 (s, 3 H, OCH3),
5.54 (br s, 1 H, aNH), 7.63 (d, J = 8.4 Hz, 2 H, ArH), 7.83
Synthesis of (E)-methyl 3-acetamido-2-(tert-
butoxycarbonylamino)but-2-enoate, E-2e
(d, J = 8.4 Hz, 2 H, ArH), 12.39 (br s, 1 H, NH) ppm. 13
C
NMR (75.4 MHz, CDCl3): 16.77 (cCH3), 28.22 [C(CH3)3],
52.16 (OCH3), 80.46 [OC(CH3)3], 105.81 (C), 127.36 (C),
129.18 (CH), 132.10 (CH), 132.98 (C), 154.46 (C=O),
154.71 (C), 164.70 (C=O), 168.54 (C=O) ppm.
C17H21BrN2O5 (413.26): calcd. C 49.41, H 5.12, N 6.78;
found C 49.31, H 5.195, N 6.774.
The general procedure described above was followed with
compound Z-1 (0.5 mmol, 147 mg) as substrate, CuI
(10 mol %) and DMED (30 mol %) for 12 h to give
compound E-2e. Column chromatography using diethyl
ether/petroleum ether ((2:1) gave compound E-2e (97 mg,
71 %) as an oil. 1H NMR (300 MHz, CDCl3): 1.46 (s, 9 H,
CH3 Boc), 2.15 (s, 3 H, CH3), 2.46 (s, 3 H, cCH3), 3.76 (s,
3 H, OCH3), 5.44 (br s, 1 H, aNH), 11.42 (br s, 1 H, NH)
ppm. 13C NMR (75.4 MHz, CDCl3): 16.55 (cCH3), 25.53
(CH3), 28.22 [C(CH3)3], 51.91 (OCH3), 80.36 [OC(CH3)3],
104.71 (C), 154.36 (C), 154.79 (C=O), 168.19 (C=O),
169.19 (C=O) ppm. HRMS (micrOTOF): calcd. for
C12H20N2NaO5 295.12699; found 295.12644.
The general procedure described above was followed
with compound E-1 (0.5 mmol, 147 mg) as substrate to
give compound E-2b. Column chromatography using die-
thyl ether/petroleum ether (1:1) gave compound E-2b
(157 mg, 76 %).
Synthesis of (E)-methyl 2-(tert-butoxycarbonylamino)-
3-(4-methoxybenzamido)but-2-enoate, E-2c
Synthesis of (E)-methyl 2,3-bis(benzamido)but-2-
enoate, E-2f
The general procedure described above was followed with
compound Z-1 (0.25 mmol, 73 mg) as substrate and CuI
(10 mol %) to give compound E-2c (53 mg, 58 %) as an
1
The general procedure described above was followed with
compound E-3 (0.25 mmol, 75 mg) as substrate giving
compound 4 (31 mg, 58 %) and compound E-2f (30 mg,
37 %). Compound E-2f was obtained as a white solid, m.
oil. H NMR (400 MHz, CDCl3): 1.49 (s, 9 H, CH3 Boc),
2.61 (s, 3 H, cCH3), 3.80 (s, 3 H, OCH3), 3.88 (s, 3 H,
OCH3), 5.49 (br s, 1 H, aNH), 6.98 (d, J = 8.8 Hz, 2 H,
ArH), 7.95 (d, J = 8.8 Hz, 2 H, ArH), 12.32 (br s, 1 H,
NH) ppm. 13C NMR (100.6 MHz, CDCl3): 16.80 (cCH3),
28.26 [C(CH3)3], 52.02 (OCH3), 55.45 (OCH3), 80.34
[OC(CH3)3], 104.97 (C), 114.07 (CH), 126.47 (C), 129.69
(CH), 154.87 (C=O), 155.18 (C), 162.96 (C), 165.22
(C=O), 168.58 (C=O) ppm. HRMS (ESI): calcd. for
C18H24N2NaO6 387.15321; found 387.15282.
1
p. 98.0–99.0 °C (from ethyl acetate/petroleum ether). H
NMR (400 MHz, CDCl3): 2.64 (s, 3 H, cCH3), 3.79 (s, 3 H,
OCH3), 7.11 (br s, 1 H, aNH), 7.44–7.61 (m, 6 H, ArH),
7.90 (m, 2 H, ArH), 8.01 (d, J = 7.6 Hz, 2 H, ArH), 12.47
(br s, 1 H, NH) ppm. 13C NMR (100.6 MHz, CDCl3):
17.12 (cCH3), 52.26 (OCH3), 104.96 (C), 127.28 (CH),
127.70 (CH), 128.77 (CH), 128.89 (CH), 132.04 (CH),
132.49 (CH), 133.99 (C), 134.09 (C), 154.73 (C), 165.74
(C=O), 167.01 (C=O), 167.96 (C=O) ppm. HRMS
The general procedure described above was followed
with compound E-1 (0.25 mmol, 73 mg) to give compound
E-2c (61 mg, 67 %).
123